Dr. Harriet Kluger, MD
Claim this profileYale Cancer Center
Studies Melanoma
Studies Renal Cell Carcinoma
5 reported clinical trials
8 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
ALK positive
2Renal Cell Carcinoma
Stage IV
Stage III
ALK positive
Affiliated Hospitals
Clinical Trials Harriet Kluger, MD is currently running
Pembrolizumab + Lenvatinib
for Skin and Kidney Cancers with Brain Metastases
This is a phase 2, Simon's 2-stage designed study with 2 cohorts of anti-PD-1/PD-L1 experienced patients with untreated brain metastases: 1) melanoma and 2) renal cell carcinoma (RCC).
Recruiting1 award Phase 212 criteria
ST-067-001
for Solid Tumors
This trial is testing a new drug called ST-067 on patients with certain types of cancer that have not responded to previous treatments. The goal is to find the safest and most effective dose and to see how well it works against these cancers.
Recruiting1 award Phase 12 criteria
More about Harriet Kluger, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Harriet Kluger, MD has experience with
- APX005M
- Nivolumab
- ST-067
- Cabiralizumab
- Ipilimumab
- Pembrolizumab Plus Bevacizumab
Breakdown of trials Harriet Kluger, MD has run
Melanoma
Renal Cell Carcinoma
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Harriet Kluger, MD specialize in?
Harriet Kluger, MD focuses on Melanoma and Renal Cell Carcinoma. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Harriet Kluger, MD currently recruiting for clinical trials?
Yes, Harriet Kluger, MD is currently recruiting for 2 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Harriet Kluger, MD has studied deeply?
Yes, Harriet Kluger, MD has studied treatments such as APX005M, Nivolumab, ST-067.
What is the best way to schedule an appointment with Harriet Kluger, MD?
Apply for one of the trials that Harriet Kluger, MD is conducting.
What is the office address of Harriet Kluger, MD?
The office of Harriet Kluger, MD is located at: Yale Cancer Center, New Haven, Connecticut 06519 United States. This is the address for their practice at the Yale Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.